{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:43Z","timestamp":1761513763246},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148929","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T19:02:34Z","timestamp":1454698954000},"page":"e0148929","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors"],"prefix":"10.1371","volume":"11","author":[{"given":"Sachin","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Termini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"Issac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"K Honda","year":"2005","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"A Le Bon","year":"2003","journal-title":"Nat Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"JE Durbin","year":"1996","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"RE Randall","year":"2008","journal-title":"Journal of General Virology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"U Muller","year":"1994","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","article-title":"Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial","volume":"321","author":"AM Di Bisceglie","year":"1989","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"JG McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"HL Janssen","year":"2005","journal-title":"Lancet"},{"key":"ref9","first-page":"602","article-title":"Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro","volume":"1","author":"DD Ho","year":"1985","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/aid.1987.3.125","article-title":"Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro","volume":"3","author":"KL Hartshorn","year":"1987","journal-title":"Aids Research and Human Retroviruses"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.2470148","article-title":"Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines","volume":"244","author":"G Poli","year":"1989","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1993.1110","article-title":"Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages","volume":"193","author":"PR Meylan","year":"1993","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-112-11-805","article-title":"Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial","volume":"112","author":"HC Lane","year":"1990","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(88)90810-0","article-title":"Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma","volume":"2","author":"R de Wit","year":"1988","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"SD Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","article-title":"Functional classification of interferon-stimulated genes identified using microarrays","volume":"69","author":"MJ de Veer","year":"2001","journal-title":"J Leukoc Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"JW Schoggins","year":"2011","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2012-01-407395","article-title":"HIV-1 infection of human macrophages directly induces viperin which inhibits viral production","volume":"120","author":"N Nasr","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"SJ Neil","year":"2008","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"M Stremlau","year":"2004","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1089\/aid.2004.20.1210","article-title":"Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages","volume":"20","author":"CH Woelk","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"T Kawai","year":"2007","journal-title":"Seminars in Immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"T Kawai","year":"2005","journal-title":"Nat Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.molcel.2005.08.014","article-title":"VISA is an adapter protein required for virus-triggered IFN-beta signaling","volume":"19","author":"LG Xu","year":"2005","journal-title":"Mol Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.ppat.1003118","article-title":"IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling","volume":"9","author":"HM Lazear","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"RB Seth","year":"2005","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.03114-13","article-title":"Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response","volume":"88","author":"D Olagnier","year":"2014","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.03129-14","article-title":"Control of HCV replication in mouse liver derived cells by MAVS-dependent production of type-I and -III interferons","author":"Anggakusuma","year":"2015","journal-title":"J Virol"},{"key":"ref29","article-title":"Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-beta-induction by efficient MAVS cleavage","author":"C Welsch","year":"2014","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.4049\/jimmunol.182.3.1593","article-title":"A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant","volume":"182","author":"K Kobiyama","year":"2009","journal-title":"Journal of Immunology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13140","article-title":"Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I","volume":"509","author":"A Peisley","year":"2014","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1073\/pnas.2237224100","article-title":"Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling","volume":"101","author":"T Yasui","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.01214-06","article-title":"LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB","volume":"80","author":"V Soni","year":"2006","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4049\/jimmunol.160.3.1116","article-title":"A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase","volume":"160","author":"E Hatzivassiliou","year":"1998","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12542","article-title":"Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection","volume":"502","author":"C Goujon","year":"2013","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2013.08.015","article-title":"The interferon-inducible MxB protein inhibits HIV-1 infection","volume":"14","author":"Z Liu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2249.2008.03750.x","article-title":"25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines","volume":"154","author":"E Scherer","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1189\/jlb.0211068","article-title":"EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine","volume":"90","author":"S Gupta","year":"2011","journal-title":"J Leukoc Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-4690-8-39","article-title":"Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines","volume":"8","author":"S Gupta","year":"2011","journal-title":"Retrovirology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/JTO.0b013e3181a8634d","article-title":"Regression of established AB1 murine mesothelioma induced by peritumoral injections of CpG oligodeoxynucleotide either alone or in combination with poly(I:C) and CD40 ligand plasmid DNA","volume":"4","author":"GW Stone","year":"2009","journal-title":"J Thorac Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.virol.2008.11.033","article-title":"Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages","volume":"385","author":"E Maurais","year":"2009","journal-title":"Virology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.1986.6.143","article-title":"Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2","volume":"6","author":"JK Yamamoto","year":"1986","journal-title":"J Interferon Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1128\/JVI.66.3.1321-1328.1992","article-title":"Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle","volume":"66","author":"Y Shirazi","year":"1992","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e1967","DOI":"10.1371\/journal.pone.0001967","article-title":"Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity","volume":"3","author":"H Rempel","year":"2008","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/aid.2009.0186","article-title":"Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production","volume":"26","author":"AR Geonnotti","year":"2010","journal-title":"Aids Research and Human Retroviruses"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/emboj.2011.123","article-title":"LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation","volume":"30","author":"FJ Verweij","year":"2011","journal-title":"Embo Journal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/aid.1990.6.1045","article-title":"Restriction of HIV replication in infected T cells and monocytes by interferon-alpha","volume":"6","author":"HE Gendelman","year":"1990","journal-title":"Aids Research and Human Retroviruses"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1073\/pnas.0603082103","article-title":"Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus","volume":"103","author":"L Gitlin","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"M Yoneyama","year":"2004","journal-title":"Nat Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/JVI.02229-13","article-title":"Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag","volume":"88","author":"S Gupta","year":"2014","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"TD Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"D Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(94)90068-X","article-title":"Multiple effects of interferon on the replication of human immunodeficiency virus type 1","volume":"24","author":"PM Pitha","year":"1994","journal-title":"Antiviral Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/JVI.65.7.3968-3971.1991","article-title":"Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells","volume":"65","author":"BF Fernie","year":"1991","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"H Kato","year":"2006","journal-title":"Nature"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"17264","DOI":"10.1073\/pnas.0407639101","article-title":"The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter","volume":"101","author":"J Andrejeva","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"E Meylan","year":"2005","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e29291","DOI":"10.1371\/journal.pone.0029291","article-title":"Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA","volume":"7","author":"RK Berg","year":"2012","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JVI.01635-10","article-title":"RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I","volume":"85","author":"M Solis","year":"2011","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1189\/jlb.0313158","article-title":"RIG-I activation inhibits HIV replication in macrophages","volume":"94","author":"Y Wang","year":"2013","journal-title":"J Leukoc Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"46335","DOI":"10.1074\/jbc.M403966200","article-title":"The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes","volume":"279","author":"J Zhang","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response","volume":"81","author":"RH Silverman","year":"2007","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"J Lu","year":"2011","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-4690-8-94","article-title":"A whole genome screen for HIV restriction factors","volume":"8","author":"L Liu","year":"2011","journal-title":"Retrovirology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/384184a0","article-title":"CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5","volume":"384","author":"A Trkola","year":"1996","journal-title":"Nature"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.187.8.1215","article-title":"Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity","volume":"187","author":"M Mack","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.1074\/jbc.M108232200","article-title":"Association of chemokine-mediated block to HIV entry with coreceptor internalization","volume":"277","author":"SM Brandt","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"F McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1128\/JVI.00854-10","article-title":"Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells","volume":"84","author":"C Goujon","year":"2010","journal-title":"J Virol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"KJ Ishii","year":"2008","journal-title":"Nature"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.4049\/jimmunol.1203470","article-title":"Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization","volume":"190","author":"H Xiao","year":"2013","journal-title":"Journal of Immunology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant","volume":"206","author":"MP Longhi","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection","volume":"11","author":"Y Wang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"XD Li","year":"2013","journal-title":"Science"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"NG Sandler","year":"2014","journal-title":"Nature"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T19:37:04Z","timestamp":1692214624000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148929"}},"subtitle":[],"editor":[{"given":"Chen","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148929","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}